Psychotropic Medication Use in Vulnerable Child and Adolescent Populations

Dingle, Arden D.

Saturday, October 30, 2010: 8:30 AM-11:30 AM

Chair:

Arden D. Dingle, M.D.

Discussant:

Gabrielle A. Carlson, MD

44.1

Ethical and Community Practice Dimensions of Off-Label Antipsychotic and Anticonvulsant Mood Stabilizer Medications
Julie M. Zito, Ph.D. University of Maryland, Baltimore, MD

44.2

Psychotropic Medication Prescriptions within a Juvenile Justice Setting
Sarghi Sharma, M.D. University of Texas Medical Branch, Galveston, TX
Joseph V. Penn, M.D. UTMB - Correctional Managed Care, Huntsville, TX

44.3

Linking Provider and Parent-Reported Medication Treatment Data with Agency Data: Can We Conclude Appropriateness and Safety?
Bonnie T. Zima, M.D., M.P.H. University of California at Los Angeles Health Services Research Center, Los Angeles, CA
Regina Bussing, M.D., M.S. University of Florida College of Medicine, Gainesville, FL
Lingqi Tang, Ph.D. University of California at Los Angeles Health Services Research Center, Los Angeles, CA
Lily L. Zhang, M.S. University of California at Los Angeles Health Services Research Center, Los Angeles, CA

44.4

Monitoring and Review of Psychotropic Medication Prescribed to Youth in Washington State Receiving Fees for Service Medicaid Services
Christopher K. Varley, M.D. University of Washington School of Medicine, Shoreline, WA

Sponsored by the AACAP Sponsored by the AACAP Ethics Committee and the AACAP Rights and Legal Matters Committee

See more of: Symposium